Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov 3;2(1):e967151.
doi: 10.4161/2167549X.2014.967151. eCollection 2014.

The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome

Affiliations

The methyl binding domain containing protein MBD5 is a transcriptional regulator responsible for 2q23.1 deletion syndrome

Katherina Walz et al. Rare Dis. .

Erratum in

  • doi: 10.15252/emmm.201404044

Abstract

2Iq23.1 microdeletion syndrome is a recently described rare disease that includes intellectual disability, motor delay, autistic-like behaviors, and craniofacial abnormalities. Dosage insufficiency of the methyl-CpG-binding domain protein 5 (MBD5) gene was suggested as the genetic cause, since all the described patients carry a partial or total heterozygous deletion of MBD5. We reported the generation and characterization of a mouse model with haploinsufficiency for Mbd5 that confirmed this hypothesis. As in human 2q23.1 microdeletion syndrome, the MBD5 (+/GT) mouse model exhibited abnormal social behavior, cognitive impairment, and motor and craniofacial abnormalities, supporting a causal role for MBD5 in 2q23.1 microdeletion syndrome. The use of mouse neuronal cultures uncovered a deficiency in neurite outgrowth, suggesting the participation of MBD5 in neuronal processes. The study of the MBD5 (+/GT) mouse advanced our understanding of the abnormal brain development associated with behavioral and cognitive symptoms.

Keywords: 2q23.1 microdeletion syndrome; Mbd5; autism; intellectual disabilities; mouse model; transcriptional regulator.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Proliferating neural stem cells do not express MBD5. 2 month old Mbd5+/GT mice were treated with BrdU 24 h before brain collection and processed for X-gal (left panel) and BrdU immunolabeling (center panel). BrdU positive cells (arrows, merged right panel and magnified inset) in the subgranular zone do not show X gal staining, suggesting that newly generated cells in the brain do not express MBD5. GCL: granule cell layer.

References

    1. Jaillard S, Dubourg C, Gerard-Blanluet M, Delahaye A, Pasquier L, Dupont C, Henry C, Tabet AC, Lucas J, Aboura A, et al. . 2q23.1 microdeletion identified by array comparative genomic hybridisation: An emerging phenotype with angelman-like features? J Med Genet 2009; 46:847-55; PMID:18812405; http://dx.doi.org/10.1136/jmg.2008.058156 - DOI - PMC - PubMed
    1. van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Ades LC, Peters G, Gibson K, Moloney S, Novara F, et al. . The 2q23.1 microdeletion syndrome: Clinical and behavioural phenotype. Eur J Hum Genet 2010; 18:163-70; PMID:19809484; http://dx.doi.org/10.1038/ejhg.2009.152 - DOI - PMC - PubMed
    1. Talkowski ME, Mullegama SV, Rosenfeld JA, van Bon BW, Shen Y, Repnikova EA, Gastier-Foster J, Thrush DL, Kathiresan S, Ruderfer DM, et al. . Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011; 89:551-63; PMID:21981781; http://dx.doi.org/10.1016/j.ajhg.2011.09.011 - DOI - PMC - PubMed
    1. Chung BH, Stavropoulos J, Marshall CR, Weksberg R, Scherer SW, Yoon G. 2q23 de novo microdeletion involving the MBD5 gene in a patient with developmental delay, postnatal microcephaly and distinct facial features. Am J Med Genet A 2011; 155A:424-9; PMID:21271666; http://dx.doi.org/10.1002/ajmg.a.33821 - DOI - PubMed
    1. Bonnet C, Ali Khan A, Bresso E, Vigouroux C, Beri M, Lejczak S, Deemer B, Andrieux J, Philippe C, Moncla A, et al. . Extended spectrum of MBD5 mutations in neurodevelopmental disorders. Eur J Hum Genet 2013; 21:1457-61; PMID:23422940; http://dx.doi.org/10.1038/ejhg.2013.22 - DOI - PMC - PubMed